|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.59 USD | -0.46% |
|
+1.33% | -1.01% |
| Capitalization | 2.97B 2.52B 2.33B 2.2B 4.07B 276B 4.14B 27.3B 10.7B 133B 11.14B 10.91B 473B | P/E ratio 2026 * |
-6.19x | P/E ratio 2027 * | -7.14x |
|---|---|---|---|---|---|
| Enterprise value | 2.36B 2B 1.85B 1.74B 3.24B 220B 3.29B 21.69B 8.5B 106B 8.85B 8.67B 376B | EV / Sales 2026 * |
25.6x | EV / Sales 2027 * | 24x |
| Free-Float |
59.4% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcus Biosciences, Inc.
| 1 day | -0.46% | ||
| 1 week | +1.33% | ||
| Current month | +9.21% | ||
| 1 month | +5.08% | ||
| 3 months | +8.21% | ||
| 6 months | +42.11% | ||
| Current year | -1.01% |
| 1 week | 22.07 |  | 23.87 |
| 1 month | 20 | | 23.87 |
| Current year | 18.52 | | 24.91 |
| 1 year | 7.06 | | 26.4 |
| 3 years | 6.5 | | 26.4 |
| 5 years | 6.5 | | 49.1 |
| 10 years | 6.3 | | 49.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Juan Jaen
PSD | President | 69 | 30/04/2015 |
Terry Rosen
CEO | Chief Executive Officer | 68 | 30/04/2015 |
Robert Goeltz
DFI | Director of Finance/CFO | 54 | 31/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Terry Rosen
CHM | Chairman | 68 | 30/11/2017 |
Kathryn Falberg
BRD | Director/Board Member | 66 | 17/09/2017 |
Yasunori Kaneko
BRD | Director/Board Member | 71 | 30/04/2015 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +8.22% | 0.28% | 20 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.46% | +1.33% | +200.51% | +24.42% | 2.97B | |
| -0.41% | +4.52% | -1.66% | -9.41% | 47.73B | |
| +0.24% | +2.32% | +40.57% | +21.11% | 35.48B | |
| -3.45% | +1.76% | +15.84% | -15.14% | 29.9B | |
| -2.14% | +55.13% | +312.35% | +507.53% | 30.23B | |
| +3.47% | +3.47% | +36.02% | +29.82% | 28.75B | |
| +0.51% | +0.51% | +53.62% | +193.56% | 14.93B | |
| +2.55% | +8.52% | +4,163.00% | +4,096.87% | 14.74B | |
| -0.56% | +2.82% | +73.91% | +163.73% | 14.81B | |
| -0.29% | +6.03% | +36.51% | +11.64% | 14.42B | |
| Average | -0.11% | +8.99% | +493.07% | +502.41% | 23.4B | |
| Weighted average by Cap. | -0.32% | +10.62% | +327.80% | +350.45% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 92.28M 78.36M 72.35M 68.21M 127M 8.59B 129M 848M 332M 4.13B 346M 339M 14.69B | 112M 94.8M 87.53M 82.52M 153M 10.39B 156M 1.03B 402M 5B 419M 410M 17.77B |
| Net income | -449M -381M -352M -332M -616M -41.8B -627M -4.13B -1.62B -20.11B -1.69B -1.65B -71.5B | -428M -364M -336M -317M -587M -39.85B -597M -3.94B -1.54B -19.17B -1.61B -1.57B -68.17B |
| Net Debt | -611M -519M -479M -451M -838M -56.84B -852M -5.61B -2.2B -27.34B -2.29B -2.24B -97.22B | -291M -247M -228M -215M -400M -27.11B -407M -2.68B -1.05B -13.04B -1.09B -1.07B -46.38B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/04/26 | 23.59 $ | -0.46% | 678,429 |
| 15/04/26 | 23.70 $ | +3.00% | 1,047,611 |
| 14/04/26 | 23.01 $ | +2.77% | 660,419 |
| 13/04/26 | 22.39 $ | +0.22% | 755,158 |
| 10/04/26 | 22.34 $ | -4.04% | 590,564 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RCUS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition